;PMID: 9851250
;source_file_1382.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..37] = [t:0..37]
;1)sentence:[e:42..139] = [t:42..139]
;2)section:[e:143..230] = [t:143..230]
;3)section:[e:234..312] = [t:234..312]
;4)sentence:[e:316..437] = [t:316..437]
;5)sentence:[e:438..596] = [t:438..596]
;6)sentence:[e:597..812] = [t:597..812]
;7)sentence:[e:813..951] = [t:813..951]
;8)sentence:[e:952..1048] = [t:952..1048]
;9)sentence:[e:1049..1165] = [t:1049..1165]
;10)section:[e:1169..1213] = [t:1169..1213]

;section 0 Span:0..37
;Cancer Lett  1998 Sep 25;131(2):171-5
(SEC
  (FRAG (DT:[0..6] Cancer) (NNP:[7..11] Lett) (CD:[13..17] 1998)
        (NNP:[18..21] Sep) (CD:[22..24] 25) (CD:[24..29] ;131-LRB-)
        (CD:[29..30] 2) (-RRB-:[30..31] -RRB-) (CD:[31..35] :171)
        (HYPH:[35..36] -) (CD:[36..37] 5)))

;sentence 1 Span:42..139
;Different ras gene mutational frequencies in thyroid papillary carcinomas in 
;Japan and Thailand.
;[52..55]:gene-rna:"ras"
;[87..115]:malignancy:"thyroid papillary carcinomas"
(SENT
  (NP-HLN
    (NP (JJ:[42..51] Different)
      (NML (NN:[52..55] ras) (NN:[56..60] gene))
      (JJ:[61..71] mutational) (NNS:[72..83] frequencies))
    (PP-LOC (IN:[84..86] in)
      (NP (JJ:[87..94] thyroid) (JJ:[95..104] papillary)
          (NNS:[105..115] carcinomas)))
    (PP-LOC (IN:[116..118] in)
      (NP (NNP:[120..125] Japan) (CC:[126..129] and) (NNP:[130..138] Thailand)))
    (.:[138..139] .)))

;section 2 Span:143..230
;Naito H, Pairojkul C, Kitahori Y, Yane K, Miyahara H, Konishi N, Matsunaga T,
; Hiasa Y.
(SEC
  (FRAG (NNP:[143..148] Naito) (NNP:[149..150] H) (,:[150..151] ,)
        (NNP:[152..161] Pairojkul) (NNP:[162..163] C) (,:[163..164] ,)
        (NNP:[165..173] Kitahori) (NNP:[174..175] Y) (,:[175..176] ,)
        (NNP:[177..181] Yane) (NNP:[182..183] K) (,:[183..184] ,)
        (NNP:[185..193] Miyahara) (NNP:[194..195] H) (,:[195..196] ,)
        (NNP:[197..204] Konishi) (NNP:[205..206] N) (VBD:[206..207] ,)
        (NNP:[208..217] Matsunaga) (NNP:[218..219] T) (,:[219..220] ,)
        (NNP:[222..227] Hiasa) (NNP:[228..230] Y.)))

;section 3 Span:234..312
;The Second Department of Pathology, Nara Medical University, Kashihara,
;Japan.
(SEC
  (FRAG (DT:[234..237] The) (NNP:[238..244] Second) (NNP:[245..255] Department)
        (IN:[256..258] of) (NNP:[259..268] Pathology) (,:[268..269] ,)
        (NNP:[270..274] Nara) (NNP:[275..282] Medical)
        (NNP:[283..293] University) (,:[293..294] ,) (NNP:[295..304] Kashihara)
        (,:[304..305] ,) (NNP:[306..311] Japan) (.:[311..312] .)))

;sentence 4 Span:316..437
;The incidence and pattern of ras oncogene mutations in human malignancies 
;demonstrate geographic and racial differences.
;[345..348]:gene-rna:"ras"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[316..319] The) (NN:[320..329] incidence) (CC:[330..333] and)
          (NN:[334..341] pattern))
      (PP (IN:[342..344] of)
        (NP
          (NP (NN:[345..348] ras) (NN:[349..357] oncogene)
              (NNS:[358..367] mutations))
          (PP-LOC (IN:[368..370] in)
            (NP (JJ:[371..376] human) (NNS:[377..389] malignancies))))))
    (VP (VBP:[391..402] demonstrate)
      (NP
        (NP (JJ:[403..413] geographic)
          (NML-1 (-NONE-:[413..413] *P*)))
        (CC:[414..417] and)
        (NP (JJ:[418..424] racial)
          (NML-1 (NNS:[425..436] differences)))))
    (.:[436..437] .)))

;sentence 5 Span:438..596
;For example, specificity of  alterations is found in cholangiocellular
;carcinomas in Thai patients with a  different etiology from those in Japanese
;patients.
;[491..519]:malignancy:"cholangiocellular carcinomas"
(SENT
  (S
    (PP (IN:[438..441] For)
      (NP (NN:[442..449] example)))
    (,:[449..450] ,)
    (NP-SBJ-1
      (NP (NN:[451..462] specificity))
      (PP (IN:[463..465] of)
        (NP (NNS:[467..478] alterations))))
    (VP (VBZ:[479..481] is)
      (VP (VBN:[482..487] found)
        (NP-1 (-NONE-:[487..487] *))
        (PP-LOC (IN:[488..490] in)
          (NP
            (NP (JJ:[491..508] cholangiocellular) (NNS:[509..519] carcinomas))
            (PP-LOC (IN:[520..522] in)
              (NP
                (NP (JJ:[523..527] Thai) (NNS:[528..536] patients))
                (PP (IN:[537..541] with)
                  (NP
                    (NP (DT:[542..543] a) (JJ:[545..554] different)
                        (NN:[555..563] etiology))
                    (PP (IN:[564..568] from)
                      (NP
                        (NP (DT:[569..574] those))
                        (PP-LOC (IN:[575..577] in)
                          (NP (JJ:[578..586] Japanese) (NNS:[587..595] patients)))))))))))))
    (.:[595..596] .)))

;sentence 6 Span:597..812
;In the present study, a  comparison of ras gene mutations in thyroid
;papillary carcinomas from Japanese  and Thai patients was performed using
;single-strand conformation polymorphism  and direct sequencing analyses.
;[636..639]:gene-rna:"ras"
;[658..686]:malignancy:"thyroid papillary carcinomas"
(SENT
  (S
    (PP (IN:[597..599] In)
      (NP (DT:[600..603] the) (JJ:[604..611] present) (NN:[612..617] study)))
    (,:[617..618] ,)
    (NP-SBJ-3
      (NP (DT:[619..620] a) (NN:[622..632] comparison))
      (PP (IN:[633..635] of)
        (NP
          (NP (NN:[636..639] ras) (NN:[640..644] gene)
              (NNS:[645..654] mutations))
          (PP-LOC (IN:[655..657] in)
            (NP
              (NP (JJ:[658..665] thyroid) (JJ:[666..675] papillary)
                  (NNS:[676..686] carcinomas))
              (PP (IN:[687..691] from)
                (NP-SBJ
                  (NP (JJ:[692..700] Japanese)
                    (NML-2 (-NONE-:[700..700] *P*)))
                  (CC:[702..705] and)
                  (NP (JJ:[706..710] Thai)
                    (NML-2 (NNS:[711..719] patients))))))))))
    (VP (VBD:[720..723] was)
      (VP (VBN:[724..733] performed)
        (NP-3 (-NONE-:[733..733] *))
        (S-MNR
          (NP-SBJ (-NONE-:[733..733] *))
          (VP (VBG:[734..739] using)
            (NP
              (NP
                (NML
                  (NML (JJ:[740..746] single) (HYPH:[746..747] -)
                       (NN:[747..753] strand))
                  (NN:[754..766] conformation) (NN:[767..779] polymorphism))
                (NML-1 (-NONE-:[779..779] *P*)))
              (CC:[781..784] and)
              (NP
                (NML (JJ:[785..791] direct) (NN:[792..802] sequencing))
                (NML-1 (NNS:[803..811] analyses))))))))
    (.:[811..812] .)))

;sentence 7 Span:813..951
;The incidence of ras mutation differed markedly  in Japanese (two of 24
;carcinomas, 8.3%) and Thai (five of 10 carcinomas, 50%)  patients.
;[830..833]:gene-rna:"ras"
;[885..895]:malignancy:"carcinomas"
;[924..934]:malignancy:"carcinomas"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[813..816] The) (NN:[817..826] incidence))
      (PP (IN:[827..829] of)
        (NP (NN:[830..833] ras) (NN:[834..842] mutation))))
    (VP (VBD:[843..851] differed)
      (ADVP (RB:[852..860] markedly))
      (PP-LOC (IN:[862..864] in)
        (NP
          (NP (JJ:[865..873] Japanese)
            (PRN (-LRB-:[874..875] -LRB-)
              (FRAG
                (NP
                  (NP (CD:[875..878] two))
                  (PP (IN:[879..881] of)
                    (NP (CD:[882..884] 24) (NNS:[885..895] carcinomas))))
                (,:[895..896] ,)
                (NP (CD:[897..900] 8.3) (NN:[900..901] %)))
              (-RRB-:[901..902] -RRB-))
            (NML-1 (-NONE-:[902..902] *P*)))
          (CC:[903..906] and)
          (NP (JJ:[907..911] Thai)
            (PRN (-LRB-:[912..913] -LRB-)
              (FRAG
                (NP
                  (NP (CD:[913..917] five))
                  (PP (IN:[918..920] of)
                    (NP (CD:[921..923] 10) (NNS:[924..934] carcinomas))))
                (,:[934..935] ,)
                (NP (CD:[936..938] 50) (NN:[938..939] %)))
              (-RRB-:[939..940] -RRB-))
            (NML-1 (NNS:[942..950] patients))))))
    (.:[950..951] .)))

;sentence 8 Span:952..1048
;In addition, all but one ras mutation occurred at codon 12 of the  K-ras gene
;in the Thai cases.
;[977..980]:gene-rna:"ras"
;[981..989]:variation-event:"mutation"
;[1002..1010]:variation-location:"codon 12"
;[1019..1024]:gene-rna:"K-ras"
(SENT
  (S
    (PP (IN:[952..954] In)
      (NP (NN:[955..963] addition)))
    (,:[963..964] ,)
    (NP-SBJ
      (QP (DT:[965..968] all) (IN:[969..972] but) (CD:[973..976] one))
      (NN:[977..980] ras) (NN:[981..989] mutation))
    (VP (VBD:[990..998] occurred)
      (PP-LOC (IN:[999..1001] at)
        (NP
          (NP (NN:[1002..1007] codon) (CD:[1008..1010] 12))
          (PP (IN:[1011..1013] of)
            (NP (DT:[1014..1017] the) (NN:[1019..1024] K-ras)
                (NN:[1025..1029] gene)))))
      (PP (IN:[1030..1032] in)
        (NP (DT:[1033..1036] the) (JJ:[1037..1041] Thai)
            (NNS:[1042..1047] cases))))
    (.:[1047..1048] .)))

;sentence 9 Span:1049..1165
;These results suggest that thyroid cancers in  Thailand may be due to
;specific genetic and/or environmental factors.
;[1076..1091]:malignancy:"thyroid cancers"
(SENT
  (S
    (NP-SBJ (DT:[1049..1054] These) (NNS:[1055..1062] results))
    (VP (VBP:[1063..1070] suggest)
      (SBAR (IN:[1071..1075] that)
        (S
          (NP-SBJ
            (NP (JJ:[1076..1083] thyroid) (NNS:[1084..1091] cancers))
            (PP-LOC (IN:[1092..1094] in)
              (NP (NNP:[1096..1104] Thailand))))
          (VP (MD:[1105..1108] may)
            (VP (VB:[1109..1111] be)
              (PP-PRD (JJ:[1112..1115] due)
                (PP (TO:[1116..1118] to)
                  (NP (JJ:[1119..1127] specific)
                    (NML
                      (NML (JJ:[1128..1135] genetic)
                        (NML-1 (-NONE-:[1135..1135] *P*)))
                      (CC:[1136..1142] and/or)
                      (NML (JJ:[1143..1156] environmental)
                        (NML-1 (NNS:[1157..1164] factors))))))))))))
    (.:[1164..1165] .)))

;section 10 Span:1169..1213
;PMID: 9851250 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1169..1173] PMID) (::[1173..1174] :) (CD:[1175..1182] 9851250)
        (IN:[1183..1184] -LSB-) (NNP:[1184..1190] PubMed) (HYPH:[1191..1192] -)
        (JJ:[1193..1200] indexed) (IN:[1201..1204] for)
        (NNP:[1205..1213] MEDLINE-RSB-)))
